Hypoglycemic agent screening by LC-MS/MS

Area of Science:

• Clinical Chemistry
• Analytical Chemistry
• Endocrinology

Background:

• Hypoglycemia is a critical condition with diverse causes, including physiological states and pharmaceutical agents.
• Accurate diagnosis, particularly for conditions like insulinomas, necessitates excluding drug-induced hypoglycemia.
• Common diabetes mellitus treatments, such as sulfonylureas, meglitinides, and thiazolidinediones, can dangerously lower blood glucose levels.

Purpose of the Study:

• To present a liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay for detecting hypoglycemia-inducing drugs.
• To provide a tool for qualitative or quantitative assessment of common glucose-lowering medications.
• To assist in the differential diagnosis of hypoglycemia by identifying drug-induced causes.

Main Methods:

• Development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay.
• Qualitative and quantitative analysis of common sulfonylurea, meglitinide, and thiazolidinedione drugs.
• Application of the assay in the context of differential diagnosis for hypoglycemia.

Main Results:

• The developed LC-MS/MS assay enables the detection of frequently used hypoglycemia-inducing drugs.
• The assay provides both qualitative and quantitative analytical capabilities.
• Demonstrated utility of the assay in differentiating drug-induced hypoglycemia from other causes.

Conclusions:

• The LC-MS/MS assay is a valuable tool for identifying common drugs that cause hypoglycemia.
• This method aids clinicians in the differential diagnosis of hypoglycemia, especially when drug use is suspected.
• The assay supports the accurate assessment of patients experiencing dangerously low blood glucose concentrations due to medication.